CS10 — Cagrilintide 5mg + Semaglutide 5mg 10mg (10 Vials)

CS10 is a combination peptide formulation that merges Cagrilintide and Semaglutide, designed for research on metabolic regulation, appetite control, and glucose homeostasis. This blend is suitable for studies on weight management, diabetes, and metabolic syndrome.

Research Uses:

• Appetite regulation and weight management studies
• Glucose metabolism and insulin sensitivity research
• Metabolic syndrome and obesity-related experiments

Disclaimer:

All peptide-related content on inVastor is strictly educational. inVastor does not sell, handle, distribute, or endorse the use of any peptides or research compounds. Third-party vendors on our platform may list materials intended solely for laboratory research conducted by qualified professionals. These materials are not approved for human or veterinary use, consumption, diagnosis, treatment, or therapy. No medical or practical usage guidance is provided or implied. By using our platform, you agree that all content is informational only and not a substitute for professional advice.